Steward hospital sales take effect Monday. Here’s what that means for health care in Massachusetts.
Steward Health Care leaves behind a hospital landscape that has been weakened by the company's meltdown and its closure of five hospitals over the past decade.
Embattled CEO of Steward Health Care stepping down
The embattled CEO of Steward Health Care is stepping down next month, the system announced Saturday.Dr. Ralph De La Torre’s decision to<a class="excerpt-read-more" href=" More
Embattled Steward Health Care CEO Ralph de la Torre to resign
The Senate approved a resolution​ on Wednesday that was intended to hold Ralph de la Torre in criminal contempt for failing to testify​ before a committee.
Steward Health Care CEO to step down
The CEO of a hospital operator that filed for bankruptcy protection in May will step down after failing to testify before a U.S. Senate panel.
Steward Health CEO steps down amid Senate scrutiny
A spokesperson for de la Torre said Saturday that he “has amicably separated from Steward on mutually agreeable terms”
Steward Health Care CEO Ralph de la Torre to resign
Ralph de la Torre will step down from his role as CEO of Steward Health Care as the for-profit network of hospitals and healthcare continues to undergo bankruptcy proceedings, his personal spokesperson told Boston 25 News Saturday.
Steward Health Care CEO Ralph de la Torre to step down Tuesday
The CEO of a hospital operator that filed for bankruptcy protection in May will step down after failing to testify before a U.S. Senate panel.
Steward Health CEO Who Refused to Testify to US Senate Will Step Down
Ralph de la Torre will step down as CEO of troubled Steward Health Care next week, the company said on Saturday, after he was held in criminal contempt by the U.S. Senate for refusing to testify about cost-cutting decisions at the group's 31 hospitals before it filed for bankruptcy.
CEO of Steward Health Care, whose Massachusetts hospitals folded, to step down
Steward Health Care CEO Ralph de la Torre will be stepping down after refusing to testify before a U.S. Senate panel on how his health care company went belly up — earning him a referral to a
Steward CEO leaves bankrupt hospital company
Dr. Ralph de la Torre, CEO of Dallas-based Steward Health Care, who was held in contempt of Congress for refusing to testify about the company's bankruptcy, is leaving the troubled company.
Steward Health CEO to step down from the company
The embattled CEO of Steward Health Care is stepping down from the company, his spokesperson confirmed Saturday. Dr. Ralph de la Torre is a former heart surgeon who climbed the career ladder to become founder and CEO of the now struggling for-profit health care company.
Healthcare Dive20d
Steward Health Care auction: What assets sold, closed and are still up for grabs
Editor’s note: Want to get Steward updates ... 50 ambulatory care locations and 83 physician practices spread across Rhode Island and Massachusetts. The health system brokered the deal with ...
USA Today10d
Senate panel approves civil, criminal contempt actions for Steward Health Care CEO
The panel is seeking civil and criminal action against Ralph de la Torre, the CEO of Steward Health Care, following a 20-0 vote on both resolutions, with one abstention. The senators approved a ...
NECN4d
Senate refers Steward Health Care CEO for criminal contempt prosecution
The U.S. Senate approved a resolution Wednesday intended to hold Steward Health Care CEO Ralph de la Torre in criminal contempt for failing to testify before a Senate panel. The Senate approved ...
Reuters4d
US Senate votes to hold Steward Health CEO in criminal contempt
Sept 25 (Reuters) - The U.S. Senate voted to hold Steward Health Care CEO Ralph de la Torre in ... reaching billions of people worldwide every day. Reuters provides business, financial, ...
Boston.com3d
Senate approves criminal contempt resolution against Steward Health Care CEO
BOSTON (AP) — The U.S. Senate approved a resolution Wednesday intended to hold Steward Health Care CEO Ralph de la Torre in criminal contempt for failing to testify before a Senate panel.